#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Breast angiosarcoma Fatty acid oxidation disorder Familial hypertriglyceridaemia Pseudomyxoma peritonei Amyotrophic lateral sclerosis Carcinoid syndrome Urethral valves Chronic lymphocytic leukaemia refractory PIK3CA-activated mutation Hereditary ataxia Porphyria non-acute Breast cancer Pneumonia Emphysema IPEX syndrome More trials…

    Learn about Rare Diseases

    Wolfram syndrome – Life with Disease Hypereosinophilic syndrome – Treatment Cystic fibrosis – Diagnostics Congenital generalised lipodystrophy – Diagnostics Alport’s syndrome – Diagnostics Osteosarcoma metastatic – Treatment Undifferentiated sarcoma – Life with Disease Haemophilia B with anti factor IX – Treatment Leukoencephalopathy – Life with Disease Arterial tortuosity syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Natalizumab Tetracosactide Lovotibeglogene Autotemcel Danicamtiv ALKYLATING AGENTS Human Mesenchymal Stem Cells Promethazine Hydrochloride Montelukast Sodium Dsimc Eye103 Diazepam F44/10 Isis 696844 Carbidopa Gabapentin Polydextrose Fluorescein Sodium ATIGOTATUG Sildenafil Citrate Atazanavir More therapies…

    Learn about Your Condition

    Bladder cancer recurrent Congenital pseudarthrosis Thymoma Prostate cancer Plasma cell myeloma recurrent Double hit lymphoma Bipolar disorder Cerebrovascular accident T-cell lymphoma Essential hypertension White matter lesion Cholangiosarcoma Magnetic resonance imaging Mixed-type liposarcoma Hypocalcaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on Lomustine and Temozolomide for Newly Diagnosed Glioblastoma Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Glioblastoma
    Investigated Drugs:
    • Temozolomide
    Austria Denmark Norway Sweden

  • Study on the Effects of Rilvegostomig and Drug Combination for Patients with Advanced Gastric or Gastroesophageal Junction Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Oesophageal adenocarcinoma
    • Adenocarcinoma gastric
    Investigated Drugs:
    • Sabestomig
    • Volrustomig
    • Azd0901
    Spain

  • Study on Low-Dose Aldesleukin for Patients with Pemphigus, Mucous Membrane Pemphigoid, Polymyositis, Dermatomyositis, and Primary Sclerosing Cholangitis

    Recruiting

    2 1 1
    Investigated Diseases:
    • Mucous membrane pemphigoid
    • Polymyositis
    • Dermatomyositis
    Investigated Drugs:
    • Aldesleukin
    • Glucose
    Germany

  • Study of Ixekizumab Treatment Effects on Joint and Bone Inflammation in Patients with Axial Spondyloarthritis and Psoriatic Arthritis Using Advanced Imaging Methods

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Psoriatic arthropathy
    • Axial spondyloarthritis
    Investigated Drugs:
    • Ixekizumab
    Denmark

  • Study on Glioblastoma Treatment with Olaptesed Pegol and Radiation, with Bevacizumab or Pembrolizumab, for Patients with Unmethylated MGMT Promoter

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Glioblastoma
    Investigated Drugs:
    • Olaptesed Pegol
    • Bevacizumab
    • Temozolomide
    Germany

  • Study on the Safety and Effectiveness of Baricitinib for Children Aged 1 to 17 with Juvenile Idiopathic Arthritis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Juvenile idiopathic arthritis
    Investigated Drugs:
    • Baricitinib
    Austria Belgium Czechia Denmark France Germany +3
Previous Page
1 … 461 462 463 464 465 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!